Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
47.22
-1.15 (-2.38%)
At close: Feb 11, 2026, 4:00 PM EST
47.22
0.00 (0.00%)
After-hours: Feb 11, 2026, 4:17 PM EST
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $2.27 billion as of February 11, 2026.
Market Cap
2.27B
Enterprise Value
1.87B
1-Year Change
n/a
Ranking
Category
Stock Price
$47.22
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $2.27B, an increase of 231.60%. That is a compound annual growth rate of 221.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 2.33B | 16.75% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 2.51B |
| Wave Life Sciences | 2.50B |
| Adaptive Biotechnologies | 2.44B |
| Telix Pharmaceuticals | 2.37B |
| Ultragenyx Pharmaceutical | 2.30B |
| Mesoblast | 2.29B |
| Dianthus Therapeutics | 2.28B |
| Galapagos NV | 2.21B |